These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8904242)

  • 1. [Pseudohypoaldosteronism].
    Arai K; Naruse K; Tanabe A; Naruse M; Demura H
    Nihon Rinsho; 1996 Mar; 54(3):812-8. PubMed ID: 8904242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of amiloride-sensitive sodium channel subunits in five sporadic cases of pseudohypoaldosteronism: do they have pathologic potential?
    Arai K; Zachman K; Shibasaki T; Chrousos GP
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2434-7. PubMed ID: 10404817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional polymorphisms in the mineralocorticoid receptor and amirolide-sensitive sodium channel genes in a patient with sporadic pseudohypoaldosteronism.
    Arai K; Nakagomi Y; Iketani M; Shimura Y; Amemiya S; Ohyama K; Shibasaki T
    Hum Genet; 2003 Jan; 112(1):91-7. PubMed ID: 12483305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.
    Geller DS; Rodriguez-Soriano J; Vallo Boado A; Schifter S; Bayer M; Chang SS; Lifton RP
    Nat Genet; 1998 Jul; 19(3):279-81. PubMed ID: 9662404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid resistance.
    Zennaro MC; Lombès M
    Trends Endocrinol Metab; 2004 Aug; 15(6):264-70. PubMed ID: 15358279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monogenic hypertension].
    Bähr V; Oelkers W; Diederich S
    Med Klin (Munich); 2003 Apr; 98(4):208-17. PubMed ID: 12715144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy.
    Arai K; Tsigos C; Suzuki Y; Irony I; Karl M; Listwak S; Chrousos GP
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1019-23. PubMed ID: 7962269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No apparent mineralocorticoid receptor defect in a series of sporadic cases of pseudohypoaldosteronism.
    Arai K; Tsigos C; Suzuki Y; Listwak S; Zachman K; Zangeneh F; Rapaport R; Chanoine JP; Chrousos GP
    J Clin Endocrinol Metab; 1995 Mar; 80(3):814-7. PubMed ID: 7883835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ENaC channel as the primary determinant of two human diseases: Liddle syndrome and pseudohypoaldosteronism.
    Schild L
    Nephrologie; 1996; 17(7):395-400. PubMed ID: 8987044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.
    Pujo L; Fagart J; Gary F; Papadimitriou DT; Claës A; Jeunemaître X; Zennaro MC
    Hum Mutat; 2007 Jan; 28(1):33-40. PubMed ID: 16972228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudohypoaldosteronism due to renal and multisystem resistance to mineralocorticoids respond differently to carbenoxolone.
    Hanukoglu A; Joy O; Steinitz M; Rosler A; Hanukoglu I
    J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):105-12. PubMed ID: 9182864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1.
    Chang SS; Grunder S; Hanukoglu A; Rösler A; Mathew PM; Hanukoglu I; Schild L; Lu Y; Shimkets RA; Nelson-Williams C; Rossier BC; Lifton RP
    Nat Genet; 1996 Mar; 12(3):248-53. PubMed ID: 8589714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations in epithelial sodium channel (ENaC) subunit genes and phenotypic expression of multisystem pseudohypoaldosteronism.
    Edelheit O; Hanukoglu I; Gizewska M; Kandemir N; Tenenbaum-Rakover Y; Yurdakök M; Zajaczek S; Hanukoglu A
    Clin Endocrinol (Oxf); 2005 May; 62(5):547-53. PubMed ID: 15853823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic disorders caused by gain or loss of function of the mineralocorticoid receptor].
    Arai K; Shibasaki T
    Nihon Rinsho; 2002 Feb; 60(2):361-6. PubMed ID: 11857927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutation causing pseudohypoaldosteronism type 1 identifies a conserved glycine that is involved in the gating of the epithelial sodium channel.
    Gründer S; Firsov D; Chang SS; Jaeger NF; Gautschi I; Schild L; Lifton RP; Rossier BC
    EMBO J; 1997 Mar; 16(5):899-907. PubMed ID: 9118951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone resistance: structural and functional considerations and new perspectives.
    Zennaro MC; Hubert EL; Fernandes-Rosa FL
    Mol Cell Endocrinol; 2012 Mar; 350(2):206-15. PubMed ID: 21664233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular features of type 1 pseudohypoaldosteronism.
    Riepe FG
    Horm Res; 2009; 72(1):1-9. PubMed ID: 19571553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.
    Sartorato P; Khaldi Y; Lapeyraque AL; Armanini D; Kuhnle U; Salomon R; Caprio M; Viengchareun S; Lombès M; Zennaro MC
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):119-25. PubMed ID: 15134810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudohypoaldosteronism.
    Riepe FG
    Endocr Dev; 2013; 24():86-95. PubMed ID: 23392097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mineralocorticoid receptor in rodent retina: ontogeny and molecular identity.
    Golestaneh N; Picaud S; Mirshahi M
    Mol Vis; 2002 Jul; 8():221-5. PubMed ID: 12107409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.